NeoGenomics Laboratories is a specialized genetics laboratory providing the latest diagnostic testing technologies to the pathology and oncology Communities. Staffed with specially trained hematopathologists and cytogenetic professionals, NeoGenomics Laboratories offers testing in cancer genetics, flow cytometry, immunohistochemistry and molecular diagnostics through its network of regional laboratories.
Quote | NeoGenomics Inc. (NASDAQ:NEO)
Last: | $15.82 |
---|---|
Change Percent: | -0.13% |
Open: | $15.65 |
Close: | $15.84 |
High: | $15.98 |
Low: | $15.5213 |
Volume: | 65,306 |
Last Trade Date Time: | 07/17/2024 03:00:00 am |
News | NeoGenomics Inc. (NASDAQ:NEO)
2024-07-12 11:24:12 ET More on etc. Riskified: Strong Value Proposition, Large TAM; Multiple Expansion Likely Downgrade Alert: AMD's Uphill Battle Against Nvidia Is Getting Much Steeper Redwire: Capitalizing On The Space Economy Hollysys Automation ticks high...
2024-07-12 11:24:12 ET More on etc. Riskified: Strong Value Proposition, Large TAM; Multiple Expansion Likely Downgrade Alert: AMD's Uphill Battle Against Nvidia Is Getting Much Steeper Redwire: Capitalizing On The Space Economy Hollysys Automation ticks high...
Message Board Posts | NeoGenomics Inc. (NASDAQ:NEO)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $NEO News Article - NeoGenomics to Participate at the 22nd Annual Needham Virtual Healt | whytestocks | investorshangout | 04/11/2023 12:45:50 PM |
whytestocks: $NEO News Article - NeoGenomics to Host Investor Day on April 4, 2023 | whytestocks | investorshangout | 03/27/2023 5:20:49 PM |
whytestocks: $NEO News Article - NeoGenomics Announces Commercial Availability of the RaDaR(R) Molec | whytestocks | investorshangout | 03/16/2023 7:20:59 PM |
whytestocks: $NEO News Article - NeoGenomics to Present at the 44th Annual Raymond James Institution | whytestocks | investorshangout | 02/28/2023 5:50:47 PM |
znewcar1: $NEO 24% v5,3M c16.63 f126,303M H18.07 ML10.68 off the 20dma | znewcar1 | investorshangout | 02/23/2023 9:48:29 PM |
News, Short Squeeze, Breakout and More Instantly...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that it will report its second quarter 2024 financial results after the close of the U.S. financial markets on Monday, July 29, 2024. Company management will host a webcast and conference call at 4:30 ...
2024-06-23 10:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today announced that Fort Myers’ Mayor, Kevin Anderson, will be dedicating June as NeoGenomics’ Commitment to Cancer Month to honor cancer survivors and those currently living with cancer. Headquartered in...